This company has shut down. OncXerna Therapeutics is no longer operating — its last tracked round was a Venture - Series Unknown in 2022.
Explore the Startup GraveyardOncXerna Therapeutics offers precision medicine using an innovative RNA-based biomarker platform.
OncXerna Therapeutics has raised $30.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in March 2022.
OncXerna Therapeutics's investors include Korea Investment Partners, Panacea Venture, KB Investment, K2 HealthVentures, Nan Fung Life Sciences.
OncXerna Therapeutics is headquartered in Waltham, United States.
OncXerna Therapeutics offers precision medicine using an innovative RNA-based biomarker platform.
OncXerna Therapeutics is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"OncXerna Therapeutics — Funding & Investors." VCBacked, March 3, 2022, https://www.vcbacked.co/company/oncxerna-therapeutics. Accessed September 30, 2026.
VCBacked. (2022). OncXerna Therapeutics — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/oncxerna-therapeutics
{{cite web |title=OncXerna Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/oncxerna-therapeutics |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated